www.federalregister.gov Open in urlscan Pro
99.83.174.136 Public Scan

Back to summary

Submitted URL:
https://go.assentportal.com/83f00000-c1cf-1219-80d5-08dab7790ab3/83f00000-c1cf-1219-1383-08dab7794cb3/
Effective URL:
https://www.federalregister.gov/documents/2021/01/06/2020-28693/hexachlorobutadiene-hcbd-regulation-of-persistent-bioaccumulativ...
Submission: On October 27 via api (October 27th 2022, 5:34:07 am UTC) from US — Scanned from DE

Form analysis
6 forms found in the DOM

GET /topics

<form class="facet-explorer-search" data-autocomplete="{&quot;endpoint&quot;:&quot;/agencies/suggestions?term=&quot;}" action="/topics" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓">
  <input class="form-control fr-table-form ui-autocomplete-input" placeholder="try 'Agricultural Marketing Service'" data-autocomplete="autocomplete" autocomplete="off">
</form>

GET /topics

<form class="facet-explorer-search" data-autocomplete="{&quot;endpoint&quot;:&quot;/topics/suggestions?term=&quot;}" action="/topics" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓">
  <input class="form-control fr-table-form ui-autocomplete-input" placeholder="try 'Antidumping'" data-autocomplete="autocomplete" autocomplete="off">
</form>

GET /document_issues/search

<form id="date_selector" action="/document_issues/search" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓">
  <label>Go to a specific date:</label>
  <input type="text" name="date" id="date" value="" placeholder="MM/DD/YYYY" class="browse_search">
  <input type="submit" name="commit" value="Go" data-disable-with="Go">
</form>

GET /public_inspection_issues/search

<form id="date_selector" action="/public_inspection_issues/search" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓">
  <label>Go to a specific date:</label>
  <input type="text" name="date" id="date" value="" placeholder="MM/DD/YYYY" class="browse_search">
  <input type="submit" name="commit" value="Go" data-disable-with="Go">
</form>

GET /documents/search

<form class="search-form formtastic conditions" novalidate="novalidate" action="/documents/search" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓">
  <label for="term">Search the Federal Register</label>
  <input class="search-term" placeholder="Search Documents" aria-label="Search Documents" type="text" name="conditions[term]" id="conditions_term">
  <button name="button" type="submit" class="search-submit" id="conditions_submit" aria-label="Search"><span class="icon-fr2 icon-fr2-Search "></span></button>
</form>

POST /my/clippings

<form class="add-to-clipboard formtastic document" novalidate="novalidate" action="/my/clippings" accept-charset="UTF-8" method="post" style="display: none;"><input name="utf8" type="hidden" value="✓">
  <fieldset class="inputs">
    <ol>
      <li class="hidden input required" id="document_document_number_input"><input id="document_document_number" type="hidden" value="2020-28693" name="document[document_number]">
      </li>
    </ol>
  </fieldset>
  <fieldset class="actions">
    <ol>
      <li class="action input_action " id="document_submit_action"><input type="submit" name="commit" value="Add to clipboard" data-disable-with="Add to clipboard"></li>
    </ol>
  </fieldset>
</form>

Text Content

Skip to Content
*
* Sections
* Money
* Environment
* World
* Science & Technology
* Business & Industry
* Health & Public Welfare

* * FAIR CREDIT REPORTING

by the Consumer Financial Protection Bureau on 10/26/2022

photo by: Daniil Vin

DODD-FRANK WALL STREET REFORM

249 documents in the last year

GOVERNMENT CONTRACTS

42 documents in the last year

STOCK & COMMODITIES TRADING

511 documents in the last year

ECONOMIC SANCTIONS & FOREIGN ASSETS CONTROL

815 documents in the last year

15 New Documents In this Issue
198 Documents Open for Comment

* * ENDANGERED AND THREATENED WILDLIFE

by the Fish and Wildlife Service on 10/26/2022

photo by: Christopher Michel

ENDANGERED & THREATENED SPECIES

812 documents in the last year

FISHERY MANAGEMENT

1466 documents in the last year

TAKING OF MARINE MAMMALS

273 documents in the last year

PARKS & RECREATION

949 documents in the last year

26 New Documents In this Issue
276 Documents Open for Comment

* * BILL BRANDT/HENRY MOORE EXHIBITION

by the State Department on 10/26/2022

photo by: Annie HARADA VIOT

IMMIGRATION & BORDER CONTROL

309 documents in the last year

CULTURAL OBJECTS IMPORTED FOR EXHIBITION

81 documents in the last year

INTERNATIONAL TRADE (ANTI-DUMPING)

871 documents in the last year

CONTROLLED EXPORTS (CCL & USML)

81 documents in the last year

21 New Documents In this Issue
155 Documents Open for Comment

* * TAKES OF MARINE MAMMALS

by the National Oceanic and Atmospheric Administration on 10/26/2022

photo by: Oregon State University

BROADBAND POLICY

196 documents in the last year

PATENT, TRADEMARK, AND COPYRIGHT

1394 documents in the last year

ENERGY EFFICIENCY & RENEWABLE RESOURCES

527 documents in the last year

CLIMATE CHANGE

674 documents in the last year

35 New Documents In this Issue
374 Documents Open for Comment

* * SBA BUSINESS LOAN PROGRAMS

by the Small Business Administration on 10/26/2022

photo by: Marco Verch Professional Photographer

AUTOMOBILE SAFETY & FUEL ECONOMY

43 documents in the last year

OIL AND GAS LEASING

16 documents in the last year

AIR TRAVEL

112 documents in the last year

TRADE ADJUSTMENT ASSISTANCE

44 documents in the last year

39 New Documents In this Issue
490 Documents Open for Comment

* * MANUFACTURED HOUSING CONSENSUS COMMITTEE

by the Housing and Urban Development Department on 10/26/2022

photo by: Macomb Paynes

HEALTH CARE REFORM

170 documents in the last year

VETERANS EDUCATIONAL BENEFITS

10 documents in the last year

VETERANS EMPLOYMENT & TRAINING

24 documents in the last year

DISASTER DECLARATIONS & ASSISTANCE

971 documents in the last year

25 New Documents In this Issue
415 Documents Open for Comment

* Browse
* Agencies
* Topics (CFR Indexing Terms)
* Dates
* Public Inspection
* Presidential Documents

* EXPLORE AGENCIES

Agriculture Department 18 7 Commerce Department 56 18 Defense Department
23 7 Education Department 9 4 Energy Department 51 7 Environmental
Protection Agency 28 23 Health and Human Services Department 86 14
Homeland Security Department 76 17 Housing and Urban Development
Department 10 7 Interior Department 18 12 Justice Department 12 2 Labor
Department 11 10 State Department 6 2 Transportation Department 56 28
Treasury Department 24 7 Veterans Affairs Department 7 0

* EXPLORE TOPICS (CFR INDEXING TERMS)

Administrative practice and procedure 19 5 Air pollution control 10 4 Air
transportation 23 10 Airspace 13 4 Aviation safety 23 10 Environmental
protection 12 5 Incorporation by reference 52 19 Intergovernmental
relations 12 6 Marine safety 9 0 Navigation (air) 12 4

* CURRENT ISSUE 327 PAGES

* 113 documents from 48 agencies

* 93 Notices
* 2 Presidential Documents
* 6 Proposed Rules
* 12 Rules
* 1 Significant Document

GO TO A SPECIFIC DATE

Go to a specific date:

EXPLORE

« PrevSeptemberNext
»SMTWTFS282930311234567891011121314151617181920212223242526272829301

«
PrevOctoberSMTWTFS2526272829301234567891011121314151617181920212223242526272829303112345

* The Public Inspection page on FederalRegister.gov offers a preview of
documents scheduled to appear in the next day's Federal Register issue.
The Public Inspection page may also include documents scheduled for later
issues, at the request of the issuing agency.

* SPECIAL FILING

updated on 4:15 PM on Wednesday, October 26, 2022
9 documents from 7 agencies
* 6 Notices
* 3 Rules

* REGULAR FILING

updated on 8:45 AM on Wednesday, October 26, 2022
95 documents from 38 agencies
* 87 Notices
* 4 Proposed Rules
* 4 Rules

GO TO A SPECIFIC DATE

Go to a specific date:

EXPLORE

« PrevSeptemberNext
»SMTWTFS282930311234567891011121314151617181920212223242526272829301

«
PrevOctoberSMTWTFS2526272829301234567891011121314151617181920212223242526272829303112345

* * EXECUTIVE ORDERS VIEW

The President of the United States manages the operations of the
Executive branch of Government through Executive orders.

* Executive Order 14088
Taking Additional Steps To Address the National Emergency With Respect
to the Situation in Nicaragua
Wednesday, October 26, 2022
* Executive Order 14087
Lowering Prescription Drug Costs for Americans
Wednesday, October 19, 2022

* PROCLAMATIONS VIEW

The President of the United States communicates information on holidays,
commemorations, special observances, trade, and policy through
Proclamations.

* OTHER PRESIDENTIAL DOCUMENTS VIEW

The President of the United States issues other types of documents,
including but not limited to; memoranda, notices, determinations,
letters, messages, and orders.

* Search
* Document Search
* Advanced Document Search
* Public Inspection Search
* FR Index
* Reader Aids
* Reader Aids Home
* Office of the Federal Register Blog
* Using FederalRegister.Gov
* Understanding the Federal Register
* Recent Site Updates
* Videos & Tutorials
* Developer Resources
* Government Policy and OFR Procedures
* Congressional Review
* My FR
* My Account
* My Clipboard
* My Comments
* My Subscriptions
* Sign In / Sign Up
* Search the Federal Register

0
* Sign in
* Sign up

THE FEDERAL REGISTER

THE DAILY JOURNAL OF THE UNITED STATES GOVERNMENT

LEGAL STATUS

This site displays a prototype of a “Web 2.0” version of the daily Federal
Register. It is not an official legal edition of the Federal Register, and does
not replace the official print version or the official electronic version on
GPO’s govinfo.gov.

The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status. For
complete information about, and access to, our official publications and
services, go to About the Federal Register on NARA's archives.gov.

The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of establishing
the XML-based Federal Register as an ACFR-sanctioned publication in the future.
While every effort has been made to ensure that the material on
FederalRegister.gov is accurately displayed, consistent with the official
SGML-based PDF version on govinfo.gov, those relying on it for legal research
should verify their results against an official edition of the Federal Register.
Until the ACFR grants it official status, the XML rendition of the daily Federal
Register on FederalRegister.gov does not provide legal notice to the public or
judicial notice to the courts.

LEGAL STATUS

RULE

HEXACHLOROBUTADIENE (HCBD); REGULATION OF PERSISTENT, BIOACCUMULATIVE, AND TOXIC
CHEMICALS UNDER TSCA SECTION 6(H)

A Rule by the Environmental Protection Agency on 01/06/2021

* 1.

* New folder
* My Clipboard

DOCUMENT DETAILS

Information about this document as published in the Federal Register.

Printed version: PDF Publication Date: 01/06/2021 Agency: Environmental
Protection Agency Dates: This final rule is effective February 5, 2021. For
purposes of judicial review and 40 CFR 23.5, this rule shall be promulgated at 1
p.m. eastern standard time on January 21, 2021. Effective Date: 02/05/2021
Document Type: Rule Document Citation: 86 FR 922 Page: 922-932 (11 pages) CFR:
40 CFR 751 Agency/Docket Numbers: EPA-HQ-OPPT-2019-0080 FRL 10018-91 RIN:
2070-AK61 Document Number: 2020-28693

DOCUMENT DETAILS

DOCUMENT STATISTICS

Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views: 20,655 as of 10/27/2022 at 12:15 am EDT

DOCUMENT STATISTICS

ENHANCED CONTENT

Relevant information about this document from Regulations.gov provides
additional context. This information is not part of the official Federal
Register document.

Docket Number: EPA-HQ-OPPT-2019-0080 Docket Name: Regulation of Persistent,
Bioaccumulative, and Toxic Chemicals under TSCA Section 6(h) Docket RIN
2070-AK34 Supporting/Related Materials: Reproduction Study in Japanese Quail Fed
Hexachlorobutadiene... Price of Castrol Braycote 3214 and Brayco 599 Price of
TURBONYCOIL 600 Price of Eastman HALO 157 Toxic golf balls? Sporting good
illustrates need for prompt... EJSCREEN Report (Version 2017) - 1 mile Ring
Centered at... USEPA, Comments of Safer Chemicals Healthy Families on...
EJSCREEN Report (Version 2017) - 1 mile Ring Centered at... Phenol,
isopropylated, phosphate (3:1), Technical Report for... 75th Year of SAE A-6: A
History of Aviation Actuation, Control... See all 590 supporting documents

ENHANCED CONTENT

PUBLISHED DOCUMENT

This document has been published in the Federal Register. Use the PDF linked in
the document sidebar for the official electronic format.

PUBLISHED DOCUMENT

* ENHANCED CONTENT - TABLE OF CONTENTS

This table of contents is a navigational tool, processed from the headings
within the legal text of Federal Register documents. This repetition of
headings to form internal navigation links has no substantive legal effect.

* AGENCY:
* ACTION:
* SUMMARY:
* DATES:
* ADDRESSES:
* FOR FURTHER INFORMATION CONTACT:
* SUPPLEMENTARY INFORMATION:
* I. Executive Summary
* A. Does this action apply to me?
* B. What is the Agency's authority for taking this action?
* C. What action is the Agency taking?
* D. Why is the Agency taking this action?
* E. What are the estimated incremental impacts of this action?
* F. Children's Environmental Health
* II. Background
* A. History of This Rulemaking
* B. Other Provisions of TSCA Section 6
* C. HCBD Overview, Health Effects, and Exposure
* D. EPA's Proposed Rule Under TSCA Section 6(h) for HCBD
* E. Public Comments and Other Public Input
* F. Activities Not Directly Regulated by This Final Rule
* III. Provisions of This Final Rule
* A. Scope and Applicability
* B. TSCA Section 6(c)(2) Considerations
* C. TSCA Section 26(h) Considerations
* IV. References
* V. Statutory and Executive Order Reviews
* A. Executive Order 12866: Regulatory Planning and Review and Executive
Order 13563: Improving Regulations and Regulatory Review
* B. Executive Order 13771: Reducing Regulation and Controlling Regulatory
Costs
* C. Paperwork Reduction Act (PRA)
* D. Regulatory Flexibility Act (RFA)
* E. Unfunded Mandates Reform Act (UMRA)
* F. Executive Order 13132: Federalism
* G. Executive Order 13175: Consultation and Coordination With Indian Tribal
Governments
* H. Executive Order 13045: Protection of Children From Environmental Health
and Safety Risks
* I. Executive Order 13211: Actions Concerning Regulations That
Significantly Affect Energy Supply, Distribution, or Use
* J. National Technology Transfer and Advancement Act (NTTAA).
* K. Executive Order 12898: Federal Actions To Address Environmental Justice
in Minority Populations and Low-Income Populations
* L. Congressional Review Act (CRA)
* List of Subjects in 40 CFR Part 751
* PART 751—REGULATION OF CERTAIN CHEMICAL SUBSTANCES AND MIXTURES UNDER
SECTION 6 OF THE TOXIC SUBSTANCES CONTROL ACT
* Subpart E—Persistent, Bioaccumulative, and Toxic Chemicals

ENHANCED CONTENT - TABLE OF CONTENTS

* ENHANCED CONTENT - SUBMIT PUBLIC COMMENT

* This feature is not available for this document.

ENHANCED CONTENT - SUBMIT PUBLIC COMMENT

* ENHANCED CONTENT - READ PUBLIC COMMENTS

* This feature is not available for this document.

ENHANCED CONTENT - READ PUBLIC COMMENTS

* ENHANCED CONTENT - SHARING

Shorter Document URL https://www.federalregister.gov/d/2020-28693
* Email this document to a friend

ENHANCED CONTENT - SHARING

* ENHANCED CONTENT - DOCUMENT PRINT VIEW

* Print this document

ENHANCED CONTENT - DOCUMENT PRINT VIEW

* ENHANCED CONTENT - DOCUMENT TOOLS

These tools are designed to help you understand the official document better
and aid in comparing the online edition to the print edition.

* These markup elements allow the user to see how the document follows the
Document Drafting Handbook that agencies use to create their documents.
These can be useful for better understanding how a document is structured
but are not part of the published document itself.

Display Non-Printed Markup Elements

ENHANCED CONTENT - DOCUMENT TOOLS

* ENHANCED CONTENT - DEVELOPER TOOLS

THIS DOCUMENT IS AVAILABLE IN THE FOLLOWING DEVELOPER FRIENDLY FORMATS:

* JSON: Normalized attributes and metadata
* XML: Original full text XML
* MODS: Government Publishing Office metadata

More information and documentation can be found in our developer tools pages.

ENHANCED CONTENT - DEVELOPER TOOLS

* OFFICIAL CONTENT

* View printed version (PDF)

OFFICIAL CONTENT

* PUBLIC INSPECTION

This PDF is the current document as it appeared on Public Inspection on
01/05/2021 at 8:45 am. It was viewed 19 times while on Public Inspection.

If you are using public inspection listings for legal research, you should
verify the contents of the documents against a final, official edition of the
Federal Register. Only official editions of the Federal Register provide
legal notice to the public and judicial notice to the courts under 44 U.S.C.
1503 & 1507. Learn more here.

PUBLIC INSPECTION

PUBLISHED DOCUMENT

This document has been published in the Federal Register. Use the PDF linked in
the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Environmental Protection Agency (EPA).

ACTION:

Final rule.

SUMMARY:

The Environmental Protection Agency (EPA) is finalizing a rule under the Toxic
Substances Control Act (TSCA) to address its obligations under TSCA for
hexachlorobutadiene (HCBD) (CASRN 87-68-3), which EPA has determined meets the
requirements for expedited action under TSCA. This final rule prohibits all
manufacturing (including import), processing, and distribution in commerce of
HCBD and HCBD-containing products or articles, recognizing that there is
unintentional production of HCBD as a byproduct during the production of
chlorinated solvents, and that results in distribution in commerce of a very
limited subset of that byproduct for burning as a waste fuel. These requirements
will impact the amount of HCBD that will be manufactured, processed, distributed
in commerce, used or disposed, thus reducing the exposures to humans and the
environment from those activities prohibited under this final rule.

DATES:

This final rule is effective February 5, 2021. For purposes of judicial review
and 40 CFR 23.5, this rule shall be promulgated at 1 p.m. eastern standard time
on January 21, 2021.

ADDRESSES:

The docket for this action, identified by docket identification (ID) number
EPA-HQ-OPPT-2019-0080, is available at http://www.regulations.gov or at the
Office of Pollution Prevention and Toxics Docket (OPPT Docket), Environmental
Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg.,
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading Room is
open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal
holidays. The telephone number for the Public Reading Room is (202) 566-1744,
and the telephone number for the OPPT Docket is (202) 566-0280. Please review
the visitor instructions and additional information about the docket available
at http://www.epa.gov/ dockets.

Please note that due to the public health emergency, the EPA Docket Center
(EPA/DC) and Reading Room was closed to public visitors on March 31, 2020. Our
EPA/DC staff will continue to provide customer service via email, phone, and
webform. For further information on EPA/DC services, docket contact information
and the current status of the EPA/DC and Reading Room, please visit
https://www.epa.gov/ dockets.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

For technical information contact: Victoria Ellenbogen, Existing Chemicals Risk
Management Division, Office of Pollution Prevention and Toxics, (7404T),
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001; telephone number: (202) 564-2053; email address:
ellenbogen.victoria@epa.gov.

For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South
Clinton Ave., Rochester, NY 14620; telephone number: (202) 554-1404; email
address: TSCA-Hotline@epa.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

I. EXECUTIVE SUMMARY

A. DOES THIS ACTION APPLY TO ME?

You may be potentially affected by this action if you manufacture (including
import), process, distribute in commerce, or use hexachlorobutadiene (HCBD) and
HCBD-containing products or articles. The following list of North American
Industrial Classification System (NAICS) codes is not intended to be exhaustive,
but rather provides a guide to help readers determine whether this document
applies to them. Potentially affected entities may include:

* Petroleum Lubricating Oil and Grease Manufacturing (NAICS Code 324191);
* Other Basic Inorganic Chemical Manufacturing (NAICS Code 325180);
* All Other Basic Organic Chemical Manufacturing (NAICS Code 325199);
* Plastics Material and Resin Manufacturing (NAICS Code 325211);Start Printed
Page 923
* All Other Miscellaneous Chemical Product and Preparation Manufacturing (NAICS
Code 325998);
* All Other Plastics Product Manufacturing (NAICS Code 326199);
* All Other Rubber Product Manufacturing (NAICS Code 326299);
* Cement Manufacturing (NAICS Code 327310);
* Hazardous Waste Treatment and Disposal (NAICS Code 562211);
* Hazardous Waste Collection (562112);
* Solid Waste Combustors and Incinerators (NAICS Code 562213);
* Other Chemical and Allied Products Merchant Wholesalers (NAICS Code 424690);
* Crude Petroleum Extraction (NAICS Code 211120);
* Facilities Support Services (NAICS Code 561210);
* All Other Miscellaneous Chemical Product and Preparation Manufacturing (NAICS
Code 325998).

If you have any questions regarding the applicability of this action to a
particular entity, consult the technical information contact listed under FOR
FURTHER INFORMATION CONTACT.

B. WHAT IS THE AGENCY'S AUTHORITY FOR TAKING THIS ACTION?

Section 6(h) of TSCA, 15 U.S.C. 2601 et seq., directs EPA to issue a final rule
under TSCA section 6(a) on certain persistent, bioaccumulative, and toxic (PBT)
chemical substances. HCBD (CASRN 87-68-3), which is produced only as a byproduct
in the production of chlorinated solvents, is one such chemical substance. More
specifically, EPA must take action on those chemical substances identified in
the 2014 Update to the TSCA Work Plan for Chemical Assessments (Ref. 1) that,
among other factors, EPA has a reasonable basis to conclude are toxic and that
with respect to persistence and bioaccumulation score high for one and either
high or moderate for the other, pursuant to the TSCA Work Plan Chemicals:
Methods Document. (Ref. 2) TSCA section 6(h) directs EPA to take expedited
action on the substance to reduce exposure to the substance, including to
exposure to the substance as an impurity or byproduct, to the extent
practicable. This final rule is final agency action for purposes of judicial
review under TSCA section 19(a).

C. WHAT ACTION IS THE AGENCY TAKING?

EPA published a proposed rule on July 29, 2019 to address the five PBT chemicals
EPA identified pursuant to TSCA section 6(h) (84 FR 36728; FRL-9995-76). After
publication of the proposed rule, EPA determined to address each of the five PBT
chemicals in separate final actions. This final rule prohibits the manufacturing
(including import), processing, and distribution in commerce of HCBD and
HCBD-containing products or articles after March 8, 2021, except for the
unintentional production of HCBD as a byproduct during the production of
chlorinated solvents and the processing and distribution of the byproduct for
burning as a waste fuel. In addition, after March 8, 2021, manufacturers,
processors and distributors of HCBD or HCBD-containing products or articles must
maintain, for three years from the date the record is generated, ordinary
business records related to compliance with the prohibitions and restrictions.
This provision is not intended to require subject companies to retain records in
addition to those specified herein, except as needed pursuant to normal business
operations.

D. WHY IS THE AGENCY TAKING THIS ACTION?

EPA is issuing this final rule to fulfill EPA's obligations under TSCA section
6(h) to take timely regulatory action on PBT chemicals, including HCBD, “to
address the risks of injury to health or the environment that the Administrator
determines are presented by the chemical substance and to reduce exposure to the
substance to the extent practicable.” Consistent with that requirement, the
Agency is finalizing this rule to reduce exposures to HCBD that could occur from
prohibited activities to the extent practicable.

E. WHAT ARE THE ESTIMATED INCREMENTAL IMPACTS OF THIS ACTION?

EPA has evaluated the potential costs of these restrictions and prohibitions and
the associated reporting and recordkeeping requirements. The “Economic Analysis
for Regulation of Hexachlorobutadiene (HCBD) Under TSCA Section 6(h)” (Economic
Analysis) (Ref. 3), is available in the docket and is briefly summarized here.

* Benefits. EPA was not able to quantify the benefits of reducing the potential
for human and environmental exposures to HCBD. As discussed in more detail in
Unit II., EPA did not perform a risk evaluation for HCBD, nor did EPA develop
quantitative risk estimates. Therefore, the Economic Analysis (Ref. 3)
qualitatively discusses the benefits of reducing the potential for exposure
under the final rule for HCBD.
* Costs. Total quantified annualized social costs for this final rule are
approximately $77,900 (at both 3% and 7% discount rates). Potential
unquantified costs and are those associated with testing, reformulation,
importation of articles, foregone profits, and indirect costs. The limited
data available for those costs prevents EPA from constructing a quantitative
assessment.
* Small entity impacts. This final rule will impact approximately one small
entity; which is not expected to incur impacts of 1% or greater of their
revenue.
* Environmental Justice. This final rule will increase the level of protection
for all affected populations without having any disproportionately high and
adverse human health or environmental effects on any population, including
any minority or low-income population or children.
* Effects on State, local, and Tribal governments. This final rule will not
have any significant or unique effects on small governments, or federalism or
tribal implications.

F. CHILDREN'S ENVIRONMENTAL HEALTH

Executive Order 13045 applies if the regulatory action is economically
significant and concerns an environmental health risk or safety risk that may
disproportionately affect children. While the action is not subject to Executive
Order 13045, the Agency's Policy on Evaluating Health Risks to Children
(https://www.epa.gov/ children/ epas-policy-evaluating-risk-children) is to
consider the risks to infants and children consistently and explicitly during
its decision making process. This final rule will reduce the exposure that could
occur from activities now prohibited under this final rule to HCBD for the
general population and for potentially exposed or susceptible subpopulations
such as children. More information can be found in the Exposure and Use
Assessment (Ref. 5).

II. BACKGROUND

A. HISTORY OF THIS RULEMAKING

TSCA section 6(h) requires EPA to take expedited regulatory action under TSCA
section 6(a) for certain PBT chemicals identified in the 2014 Update to the TSCA
Work Plan for Chemical Assessments (Ref. 1). As required by the statute, EPA
issued a proposed rule to address five PBT chemicals identified pursuant to TSCA
section 6(h) (84 FR 36728, July 29, 2019). The statute required that this be
followed by promulgation of a final rule no later than 18 months after the
proposal. Although EPA proposed regulatory actions on each chemical substance in
one proposal, in response to public comments (EPA-HQ-OPPT-2019-Start Printed
Page 9240080-0544), (EPA-HQ-OPPT-2019-0080-0553), (EPA-HQ-OPPT-2019-0080-0556),
(EPA-HQ-OPPT-2019-0080-0562) requesting these five actions be separated, EPA is
finalizing five separate actions to individually address each of the PBT
chemicals. EPA intends for the five separate final rules to publish in the same
issue of the Federal Register. More discussion on these comments is in the
Response to Comments document which is available in the docket (Ref. 4). The
details of the proposal for HCBD are described in more detail in Unit II.D.

Under TSCA section 6(h)(1)(A), the chemical substances subject to expedited
action are those that:

* EPA has a reasonable basis to conclude are toxic and that with respect to
persistence and bioaccumulation score high for one and either high or
moderate for the other, pursuant to the 2012 TSCA Work Plan Chemicals:
Methods Document or a successor scoring system;
* Are not a metal or a metal compound; and
* Are chemical substances for which EPA has not completed a TSCA Work Plan
Problem Formulation, initiated a review under TSCA section 5, or entered into
a consent agreement under TSCA section 4, prior to June 22, 2016, the date
that TSCA was amended by the Frank R. Lautenberg Chemical Safety for the 21st
Century Act (Pub. L. 114-182, 130 Stat. 448).

In addition, in order for a chemical substance to be subject to expedited
action, TSCA section 6(h)(1)(B) states that EPA must find that exposure to the
chemical substance under the conditions of use is likely to the general
population or to a potentially exposed or susceptible subpopulation identified
by the Administrator (such as infants, children, pregnant women, workers, or the
elderly), or to the environment on the basis of an exposure and use assessment
conducted by the Administrator. TSCA sections 6(h)(2) further provides that the
Administrator shall not be required to conduct risk evaluations on chemical
substances that are subject to TSCA section 6(h)(1).

Based on the criteria set forth in TSCA section 6(h), EPA proposed to determine
that five chemical substances meet the TSCA section 6(h)(1)(A) criteria for
expedited action, and HCBD is one of these five chemical substances. In
addition, in accordance with the statutory requirements to demonstrate that
exposure to the chemical substance is likely under the conditions of use, EPA
conducted an Exposure and Use Assessment for HCBD. As described in the proposed
rule, EPA conducted a literature review with respect to HCBD to identify,
screen, extract, and evaluate the reasonably available information on use and
exposures. This information is in the document entitled “Exposure and Use
Assessment of Five Persistent, Bioaccumulative and Toxic Chemicals” (Ref. 5).
Based on this review, which was subject to peer review and public comment, EPA
proposed to find that exposure to HCBD is likely, based on information detailed
in the Exposure and Use Assessment.

B. OTHER PROVISIONS OF TSCA SECTION 6

1. EPA's approach for implementing TSCA section 6(h)(4).

TSCA section 6(h)(4) requires EPA to issue a final TSCA section 6(a) rule to
“address the risks of injury to health or the environment that the Administrator
determines are presented by the chemical substance and reduce exposure to the
substance to the extent practicable.” EPA reads this text to require action on
the chemical, not specific conditions of use.

The approach EPA takes is consistent with the language of TSCA section 6(h)(4)
and its distinct differences from other provisions of TSCA section 6 for
chemicals that are the subject of required risk evaluations. First, the term
“condition of use” is only used in TSCA section 6(h) in the context of the TSCA
section 6(h)(1)(B) finding relating to likely exposures under “conditions of
use” to “the general population or to a potentially exposed or susceptible
subpopulation . . . or the environment.” In contrast to the risk evaluation
process under TSCA section 6(b), this TSCA section 6(h)(1)(B) threshold
criterion is triggered only through an Exposure and Use Assessment regarding the
likelihood of exposure and does not require identification of every condition of
use. As a result, EPA collected all the information it could on the use of each
chemical substance, without regard to whether any chemical activity would be
characterized as “known, intended or reasonably foreseen to be manufactured,
processed, distributed in commerce, used, or disposed of,” and from that
information created use profiles and then an Exposure and Use Assessment (Ref.
4) to make the TSCA section 6(h)(1)(B) finding for at least one or more
“condition of use” activities where some exposure is likely. EPA did not attempt
to precisely classify all activities for each chemical substance as a “condition
of use” and thus did not attempt to make a TSCA section 6(h)(1)(B) finding for
all chemical activities summarized in the Exposure and Use Assessment (Ref. 4).
Second, TSCA section 6 generally requires a risk evaluation under TSCA section
6(b) for chemicals based on the identified conditions of use. However, pursuant
to TSCA section 6(h)(2), for chemical substances that meet the criteria of TSCA
section 6(h)(1), a risk evaluation is neither required nor contemplated to be
conducted for EPA to meet its obligations under TSCA section 6(h)(4). Rather, as
noted in Unit II.B.3., if a previously prepared TSCA risk assessment exists, EPA
would have authority to use that risk assessment to “address risks” under TSCA
section 6(h)(4), but even that risk assessment would not necessarily be focused
on whether an activity is “known, intended or reasonably foreseen,” as those
terms were not used in TSCA prior to the 2016 amendments and a preexisting
assessment of risks would have had no reason to use such terminology or make
such judgments. It is for this reason EPA believes that the TSCA section 6(h)(4)
“address risk” standard refers to the risks the Administrator determines “are
presented by the chemical substance” and makes no reference to “conditions of
use.” Congress did not contemplate or require a risk evaluation identifying the
conditions of use as defined under TSCA section 3(4). The kind of analysis
required to identify and evaluate the conditions of use for a chemical substance
is only contemplated in the context of a TSCA section 6(b) risk evaluation, not
in the context of an expedited rulemaking to address PBT chemicals. Similarly,
the TSCA amendments require EPA to “reduce exposure to the substance to the
extent practicable,” without reference to whether the exposure is found “likely”
pursuant to TSCA section 6(h)(1)(B).

Taking all of this into account, EPA reads its TSCA section 6(h)(4) obligation
to apply to the chemical substance generally, thus requiring EPA to address
risks and reduce exposures to the chemical substance without focusing on whether
the measure taken is specific to an activity that might be characterized as a
“condition of use” as that term is defined in TSCA section 3(4) and interpreted
by EPA in the Risk Evaluation Rule, 82 FR 33726 (July 20, 2017). This approach
ensures that any activity involving a TSCA section 6(h) PBT chemical, past,
present or future, is addressed by the regulatory approach taken. Thus, under
this final rule, manufacturing, processing, and distribution in commerce
activities that are not specifically excluded are prohibited. The specified
excluded activities are those which EPA determined were not appropriate to Start
Printed Page 925regulate under the TSCA section 6(h)(4) standard. Consistently,
based on the Exposure and Use Assessment, activities associated with HCBD that
are no longer occurring are addressed by this rule and thus the prohibitions
adopted in this rule reduce the exposures that will result with resumption of
past activities or the initiation of similar or other activities in the future.
Therefore, EPA has determined that prohibiting these activities will reduce
exposures to the extent practicable. The approach taken for this final rule is
limited to implementation of TSCA section 6(h) and is not relevant to any other
action under TSCA section 6 or other TSCA statutory actions.

2. EPA's interpretation of “practicable.”

The term “practicable” is not defined in TSCA. EPA interprets this requirement
as generally directing the Agency to consider such factors as achievability,
feasibility, workability, and reasonableness. In addition, EPA's approach to
determining whether particular prohibitions or restrictions are practicable is
informed in part by certain other provisions in TSCA section 6, such as TSCA
section 6(c)(2)(A), which requires the Administrator to consider health effects,
exposure, and environmental effects of the chemical substance; benefits of the
chemical substance; and the reasonably ascertainable economic consequences of
the rule. In addition, pursuant to TSCA section 6(c)(2)(B), in selecting the
appropriate TSCA section 6(a) regulatory approach, the Administrator is directed
to “factor in, to the extent practicable” those same considerations.

EPA received comments on the proposed rule regarding this interpretation of
“practicable.” EPA has reviewed these comments and believes the interpretation
described previously within this Unit is consistent with the intent of TSCA and
has not changed that interpretation. EPA's interpretation of an ambiguous
statutory term receives deference. More discussion on these comments is in the
Response to Comments document for this rulemaking (Ref. 4).

3. EPA did not conduct a risk evaluation or assessment.

As EPA explained in the proposed rule, EPA does not interpret the “address risk”
language to require EPA to determine, through a risk assessment or risk
evaluation, whether risks are presented. EPA believes this reading gives the
Administrator the flexibility Congress intended for issuance of expedited rules
for PBTs and is consistent with TSCA section 6(h)(2), which makes clear a risk
evaluation is not required to support this rulemaking.

EPA received comments on the proposed rule regarding its interpretation of TSCA
section 6(h)(4) and regarding EPA's lack of risk assessment or risk evaluation
of HCBD. A number of commenters asserted that while EPA was not compelled to
conduct a risk evaluation, EPA should have conducted a risk evaluation under
TSCA section 6(b) regardless. The rationales provided by the commenters for such
a risk assessment or risk evaluation included that one was needed for EPA to
fully quantify the benefits to support this rulemaking, and that without a risk
evaluation, EPA would not be able to determine the benefits, risks, and cost
effectiveness of the rule in a meaningful way. As described by the commenters,
EPA would therefore not be able to meet the TSCA section 6(c)(2) requirement for
a statement of these considerations. Regarding the contradiction between the
mandate in TSCA section 6(h) to expeditiously issue a rulemaking and the time
needed to conduct a risk evaluation, some commenters stated that EPA would have
had enough time to conduct a risk evaluation and issue a proposed rule by the
statutory deadline.

EPA disagrees with the commenters' interpretation of EPA's obligations with
respect to chemicals subject to TSCA section 6(h)(4). TSCA section 6(h)(4)
provides that EPA shall: (1) “Address the risks of injury to health or the
environment that the Administrator determines are presented by the chemical
substance” and (2) “reduce exposure to the substance to the extent practicable.”
With respect to the first requirement, that standard is distinct from the
“unreasonable risk” standard for all other chemicals for which a section 6(a)
rule might be issued. EPA does not believe the TSCA section 6(h) contemplates a
new evaluation of any kind, given evaluations to determine risks are now
addressed through the TSCA section 6(b) risk evaluation process and TSCA section
6(h)(2) explicitly provides that no risk evaluation is required. Moreover, it
would have been impossible to prepare a meaningful evaluation under TSCA and
subsequently develop a proposed rule in the time contemplated for issuance of a
proposed rule under TSCA section 6(h)(1). Although EPA does not believe the
statute contemplates a new evaluation of any kind for these reasons, EPA
reviewed the hazard and exposure information on the five PBT chemicals EPA had
compiled. However, while this information appropriately addresses the criteria
of TSCA section 6(h)(1)(A) and (B), it did not provide a basis for EPA to
develop sufficient and scientifically robust and representative risk estimates
to evaluate whether or not any of the chemicals present an identifiable risk of
injury to health or the environment.

Rather than suggesting a new assessment is required, EPA reads the “address
risk” language in TSCA section 6(h)(4) to contemplate reliance on an existing
EPA assessment under TSCA, similar to a risk assessment that may be permissibly
used under TSCA section 26(l)(4) to regulate the chemical under TSCA section
6(a). This interpretation gives meaning to the “address risk” phrase, without
compelling an evaluation contrary to TSCA section 6(h)(2) and would allow use of
an existing determination, or development of a new determination based on such
an existing risk assessment, in the timeframe contemplated for issuance of a
proposed rule under TSCA section 6(h). However, there were no existing EPA
assessments of risk for any of the PBT chemicals. Thus, because EPA had no
existing EPA risk assessments or determinations of risk, the regulatory measures
addressed in this final rule focus on reducing exposures “to the extent
practicable.”

In sum, because neither the statute nor the legislative history suggests that a
new evaluation is compelled to identify and thereby provide a basis for the
Agency to “address risks” and one could not be done prior to preparation and
timely issuance of a proposed rule, and no existing TSCA risk assessment exists
for any of the chemicals, EPA has made no risk determination finding for any of
the PBT chemicals. Instead, EPA implements the requirement of TSCA section
6(h)(4) by reducing exposures of each PBT chemical “to the extent practicable.”

For similar reasons, EPA does not believe that TSCA section 6(c)(2) requires a
quantification of benefits, much less a specific kind of quantification. Under
TSCA section 6(c)(2)(A)(iv), EPA must consider and publish a statement, based on
reasonably available information, on the reasonably ascertainable economic
consequences of the rule, but that provision does not require quantification,
particularly if quantification is not possible. EPA has reasonably complied with
this requirement by including a quantification of direct costs and a qualitative
discussion of benefits in each of the preambles to the final rules. EPA was
unable to quantify the indirect costs associated with the rule. Further
discussion on these issues raised in the Start Printed Page 926comments is in
the Response to Comment document. (Ref. 4)

C. HCBD OVERVIEW, HEALTH EFFECTS, AND EXPOSURE

HCBD is a halogenated aliphatic hydrocarbon that is produced as a byproduct
during the manufacture of chlorinated hydrocarbons, particularly
perchloroethylene, trichloroethylene, and carbon tetrachloride (Ref. 6). As
described in the proposed rule, the majority of HCBD that is unintentionally
produced as a byproduct is destroyed via incineration by the manufacturer, which
EPA views as being consistent with the approach taken at the international level
under Article 6 of the Stockholm Convention. The remainder of the HCBD byproduct
is sent off-site for incineration or for burning as a waste fuel by cement
manufacturers in cement kilns (EPA-HQ-OPPT-2016-0738-0012), an identified source
category under Annex C of the Stockholm Convention. EPA views this burning of
such waste as consistent with the approach taken at the international level
under Article 6 of the Stockholm Convention. EPA has not identified any current
intentional use of HCBD. The destruction and removal efficiency from
incineration of the HCBD byproduct is expected to be significant but not
complete, resulting in potential for air releases from incinerator flue gas and
land releases from disposal of ash and slag. Minor water releases from equipment
cleaning are possible (Ref. 5). According to EPA Toxics Release Inventory (TRI)
data, over 9 million lbs of HCBD byproduct were generated by chemical
manufacturers in reporting year 2017, with almost 8.9 million lbs treated for
destruction on-site via incineration. TRI reports show other waste management
activities of HCBD byproduct including 58,000 lbs being treated for destruction
off-site, 33,000 lbs burned for energy recovery off-site, and 2,400 lbs released
to air (Ref. 7). Exposure information for HCBD is further detailed in EPA's
Exposure and Use Assessment (Ref. 5) and discussed in the Response to Comments
(Ref. 4).

As described in EPA's Environmental and Human Health Hazards of Five Persistent,
Bioaccumulative, and Toxic Chemicals, HCBD is considered a possible human
carcinogen (Ref. 8). Inhalation and oral animal data for HCBD indicate renal,
reproductive, and developmental effects in rats (Ref. 8). Health effects
included renal adenomas and carcinomas, reduced body weight in adults, and
reduced fetal body weight. Women who are occupationally exposed may transfer
HCBD to infants via breastmilk (Ref. 5).

HCBD is toxic to aquatic life following acute and chronic exposures at very low
concentrations (Ref. 8). Data show acute toxicity in aquatic invertebrates, fish
and algae, and chronic toxicity in fish. A single toxicity test was identified
for terrestrial organisms, showing reduced chick survival in quail. The Hazard
Summary provides more information on these hazardous endpoints (Ref. 8). The
studies presented in the document entitled “Environmental and Human Health
Hazards of Five Persistent, Bioaccumulative and Toxic Chemicals (Hazard Summary)
(Ref. 8) demonstrate these hazardous endpoints. EPA did not perform a systematic
review or a weight of the scientific evidence assessment for the hazard
characterization of these chemicals. As a result, this hazard characterization
is not definitive or comprehensive. Other hazard information on these chemicals
may exist in addition to the studies summarized in the Hazard Summary that could
alter the hazard characterization.

In the 2014 Update to the TSCA Work Plan for Chemical Assessments (Ref. 1), HCBD
scored high (3) for hazard (possible human carcinogen); moderate (2) for
exposure (based on TRI data); and high (3) for persistence and bioaccumulation
(based on high environmental persistence and high bioaccumulation potential).
The overall screening score for HCBD was high (8) (Ref. 1).

In consideration of the production, use, and destruction of HCBD, the
environmental and human health hazards of HCBD, and the public comments on the
proposed rule that are further discussed in Unit III.A., EPA determines that
HCBD meets the TSCA section 6(h)(1)(A) criteria. EPA determines in accordance
with TSCA section 6(h)(1)(B) that, based on the Exposure and Use Assessment and
the reasonably available information, exposure to HCBD under the conditions of
use is likely to the general population, to a potentially exposed or susceptible
subpopulation, or to the environment. EPA's determination is based on the
opportunities for exposure throughout the lifecycle of HCBD, including the
potential for exposures, and EPA did not receive any significant comments or
information to call the exposure finding into question.

D. EPA'S PROPOSED RULE UNDER TSCA SECTION 6(H) FOR HCBD

EPA did not propose to regulate HCBD under TSCA section 6(h) because of the
limited releases and given that the potential for exposure from uses of this
chemical is already addressed by actions taken under other statutes and EPA
determined further measures would not be practicable. As discussed in the
proposed rule, HCBD is regulated under various statutes implemented by the
Federal Government, such as the Clean Air Act (CAA) and Resource Conservation
and Recovery Act (RCRA). According to TRI data, most of the HCBD manufactured in
the United States is subsequently destroyed via incineration.

EPA, however, proposed an alternative regulatory action of prohibiting the
manufacture of HCBD, which is further discussed in the proposed rule.

E. PUBLIC COMMENTS AND OTHER PUBLIC INPUT

The proposed rule provided a 60-day public comment period, with a 30-day
extension provided. (Ref. 4). The comment period closed on October 28, 2019. EPA
received a total of 48 comments, with three commenters sending multiple
submissions with attached files, for a total of 58 submissions on the proposal
for all the PBT chemicals. This includes the previous request for a comment
period extension (EPA-HQ-OPPT-2019-0080-0526). Two commenters submitted
confidential business information (CBI) or copyrighted documents with
information regarding economic analysis and market trends. Copies of all the
non-CBI documents, or redacted versions without CBI, are available in the docket
for this action.

In this preamble, EPA has responded to the major comments relevant to the HCBD
final rule. Of the comment submissions, 10 directly addressed EPA's proposal
regarding HCBD. Additional discussion related to this final action can be found
in the Response to Comments document (Ref. 4).

F. ACTIVITIES NOT DIRECTLY REGULATED BY THIS FINAL RULE

EPA is not regulating all activities or exposures to HCBD in this rule, even
though the Exposure and Use Assessment (Ref. 5) identified potential for
exposures under conditions of use. One such activity is disposal. EPA generally
presumes compliance with federal and state laws and regulations, including, for
example, RCRA and its implementing regulations and state laws, as well as the
CAA, the Clean Water Act, and the Safe Drinking Water Act (SDWA). As described
in the proposed rule, regulations promulgated under the authority of the RCRA
govern the disposal of hazardous and non-hazardous wastes. HCBD is listed as a
Start Printed Page 927hazardous constituent under Appendix VIII of 40 CFR part
261 and Appendix IX of part 264, providing EPA with authority to regulate wastes
containing this chemical, and to address releases from RCRA-permitted treatment,
storage and disposal facilities. HCBD is listed as a hazardous waste under RCRA
in 40 CFR 261.33, Hazard Waste Code U128. In addition, HCBD is a constituent
that may also cause a waste to be defined as a characteristic hazardous waste
under 40 CFR 261.24. As a hazardous waste, HCBD is subject to regulation under
40 CFR parts 262 through 265, 268, and parts 270 and 271. HCBD is also a
hazardous constituent under 40 CFR part 258, Appendix II (Criteria for Municipal
Solid Waste Landfills, or MSWLF), which is part of the groundwater assessment
program for corrective action at MSWLFs. Industrial waste (non-hazardous)
landfills and construction/demolition waste landfills are primarily regulated
under state regulatory programs, and in addition they must meet the criteria set
forth in federal regulations which may include requirements for siting,
groundwater monitoring and corrective action depending upon what types of wastes
are accepted. Disposal by underground injection is regulated under both RCRA and
SDWA.

In addition, the CAA requires EPA to regulate hazardous air pollutants (HAP)
such as HCBD. CAA section 112 requires that the Agency establish National
Emission Standards for Hazardous Air Pollutants (NESHAP) for the control of
hazardous air pollutants from both new and existing major sources. The CAA
requires the NESHAP to reflect the maximum degree of reduction in emissions of
HAP that is achievable, taking into consideration the cost of achieving the
emissions reductions, any non-air quality health and environmental impacts, and
energy requirements. This level of control is commonly referred to as maximum
achievable control technology (MACT). The CAA also establishes a minimum control
level for MACT standards known as the MACT “floor.” The MACT floor is the
minimum control level allowed for NESHAP and is defined under the CAA section
112(d)(3) (Ref. 9). The chemical manufacturers that produce HCBD are in NAICS
group 325 and therefore fall under the NESHAP regulations for miscellaneous
organic chemical manufacturing found at 40 CFR part 63 subpart FFFF. These
regulations require facilities to treat chemicals in their waste streams at high
efficiencies. For example, emissions from process vents must be reduced by
greater than or equal to 99% by weight depending on the chemical in the waste
stream. According to TRI data, chemical manufacturers that submit reports for
HCBD are treating the byproduct via incineration at greater than 99.99%
treatment efficiency with some reporting an efficiency greater than 99.9999%.
Under the CAA, facilities in certain industries are required to implement a Leak
Detection and Repair (LDAR) program to reduce fugitive air emissions. Included
in those industries are synthetic organic chemical manufacturers that produce
the HCBD byproduct. The LDAR program requires these facilities to monitor
components such as pumps, valves, connectors and compressors for leaks. When
leaks are detected, the facility is required to repair or replace the leaking
component.

In view of these comprehensive, stringent programs for addressing disposal and
air releases, EPA determined that it is not practicable to impose additional
requirements under TSCA on the disposal and air releases of the HCBD byproduct.

In addition, EPA proposed not to use its TSCA section 6(a) authorities to
directly regulate occupational exposures. As explained in the proposed rule, as
a matter of policy, EPA assumes compliance with federal and state requirements,
such as worker protection standards, unless case-specific facts indicate
otherwise. The Occupational Safety and Health Administration (OSHA) has not
established a permissible exposure limit (PEL) for HCBD. However, under section
5(a)(1) of the Occupational Safety and Health Act of 1970, 29 U.S.C. 654(a)(1),
each employer has a legal obligation to furnish to each of its employees
employment and a place of employment that are free from recognized hazards that
are causing or are likely to cause death or serious physical harm. The OSHA
Hazard Communication Standard at 29 CFR 1910.1200 requires chemical
manufacturers and importers to classify the hazards of chemicals they produce or
import, and all employers to provide information to employees about hazardous
chemicals to which they may be exposed under normal conditions of use or in
foreseeable emergencies. The OSHA standard at 29 CFR 1910.134(a)(1) requires the
use of feasible engineering controls to prevent atmospheric contamination by
harmful substances and requires the use of respirators where effective
engineering controls are not feasible. The OSHA standard at 29 CFR 1910.134(c)
details the required respiratory protection program. The OSHA standard at 29 CFR
1910.132(a) requires the use of personal protective equipment (PPE) by workers
when necessary due to a chemical hazard; 29 CFR 1910.133 requires the use of eye
and face protection when employees are exposed to hazards including liquid
chemicals; and 29 CFR 1910.138 requires the use of PPE to protect employees'
hands including from skin absorption of harmful substances. The provisions of 29
CFR 1910.132(d) and (f) address hazard assessment, PPE selection, and training
with respect to PPE required under 29 CFR 1910.133, 1910.135, 1910.136,
1910.138, and 1910.140. EPA assumes that employers will require, and workers
will use, appropriate PPE consistent with OSHA standards, taking into account
employer-based assessments, in a manner sufficient to prevent occupational
exposures that are capable of causing injury.

EPA assumes compliance with other federal requirements, including OSHA standards
and regulations. EPA does not read TSCA section 6(h)(4) to direct EPA to adopt
potentially redundant or conflicting requirements. Not only would it be
difficult to support broadly applicable and safe additional measures for each
specific activity without a risk evaluation and in the limited time for issuance
of this regulation under TSCA section 6(h), but imposing such measures without
sufficient analysis could inadvertently result in conflicting or confusing
requirements and make it difficult for employers to understand their
obligations. Furthermore, EPA cannot conclude that broadly imposing specific
measures is practicable for all of the varied workplaces. Rather, where EPA has
identified worker exposures and available substitutes, EPA is finalizing
measures to reduce those exposures. As discussed in the proposed rule, EPA
assumes that the worker protection methods used by employers, including in
response to existing OSHA standards, in addition to the regulatory measures
taken for each chemical, meaningfully reduce the potential for occupational
exposures. Although some commenters agreed with this approach, others thought
that EPA should establish worker protection requirements for those uses that
would be allowed to continue under the final rule. Information provided to EPA
before and during the public comment period on the proposed rule indicates that
employers are using engineering and process controls and providing appropriate
personal protective equipment (PPE) to their employees consistent with these
requirements, and EPA received no information on HCBD to suggest this is not the
case. Further, Start Printed Page 928EPA has not conducted a risk evaluation on
HCBD or any of the other PBT chemicals. Without a risk evaluation and given the
time allotted for this rulemaking, EPA cannot identify additional engineering or
process controls or PPE requirements that would be appropriate to each
chemical-specific circumstance. For these reasons, EPA has determined that it is
not practicable to regulate worker exposures in this rule through additional
engineering or process controls or PPE requirements.

Finally, EPA received comments regarding the use of PBT chemicals in research
and development and laboratory use. Laboratory use is addressed under newly
established 40 CFR 751.401(b) as the manufacturing, processing,
distribution-in-commerce and use of any chemical substance, or products and
articles that contain the chemical substance, for research and development, as
defined in new 40 CFR 751.403. Research and Development is defined in new 40 CFR
751.403 to mean laboratory and research use only for purposes of scientific
experimentation or analysis, or chemical research on, or analysis of, the
chemical substance, including methods for disposal, but not for research or
analysis for the development of a new product, or refinement of an existing
product that contains the chemical substance. This will allow, for example, for
samples of environmental media containing PBTs, such as contaminated soil and
water, to be collected, packaged and shipped to a laboratory for analysis.
Laboratories also must obtain reference standards containing PBTs to calibrate
their equipment, otherwise they may not be able to accurately quantify these
chemical substances in samples being analyzed. However, research to develop new
products that use PBTs subject to 40 CFR part 751, subpart E, or the refinement
of existing uses of those chemicals, is not included in this definition, and
those activities remain potentially subject to the chemical specific provisions
in 40 CFR part 751 subpart E. EPA believes it is not practicable to limit
research and development activity as defined, given the critical importance of
this activity to the detection, quantification and control of these chemical
substances.

More information on the comments received and EPA's responses can be found in
the Response to Comments document (Ref. 4).

III. PROVISIONS OF THIS FINAL RULE

A. SCOPE AND APPLICABILITY

EPA carefully considered all public comments related to the proposal. This final
rule differs from EPA's proposal by finalizing a prohibition on the
manufacturing (including import), processing, and distribution in commerce of
HCBD, and HCBD-containing products and articles, except for the unintentional
production of HCBD as a byproduct during the production of chlorinated solvents,
and the limited processing and distribution of HCBD for burning as a waste fuel.
The effective date is 30 days after publication of the final rule.

1. Regulating HCBD.

EPA received comments disagreeing with EPA's proposal not to regulate HCBD. One
commenter stated that EPA must act under TSCA section 6(h) to include a total
phase-out of the chemical (EPA-HQ-OPPT-2019-0080-0575). Another commenter stated
that by not prohibiting uses of HCBD, EPA's approach allowed ongoing exposures,
including to potentially exposed and susceptible subpopulations, and potential
expansion of uses (EPA-HQ-OPPT-2019-0080-0567). Three commenters noted that HCBD
was listed in the Stockholm Convention on Persistent Organic Pollutant (POPs)
which prohibits the intentional manufacture of HCBD and stated that the
manufacture of HCBD should be eliminated (EPA-HQ-OPPT-2019-0080-0570)
(EPA-HQ-OPPT-2019-0080-0567) (EPA-HQ-OPPT-2019-0080-0531). EPA received one
comment supporting EPA's proposal and finding that no new risk management
measures are required to reduce exposure of HCBD to the extent practicable
(EPA-HQ-OPPT-2019-0080-0557).

In response to comments, EPA is finalizing a prohibition on the manufacturing,
processing, and distribution of HCBD and HCBD-containing products or articles,
recognizing that there is unintentional production of HCBD as a byproduct during
the production of chlorinated solvents, that results in processing and
distribution in commerce of a very limited subset of that byproduct for burning
as a waste fuel. However, as explained below, EPA disagrees with commenters that
a total ban of HCBD production as a byproduct is practicable. The potential for
exposure from incineration and distribution for incineration of the byproduct is
substantially addressed by actions taken under other statutes. As discussed in
EPA's proposed rule and in Unit II.F., HCBD is regulated under various statutes
implemented by the Federal Government, such as CAA and RCRA. According to TRI
data, most of the byproduct HCBD manufactured in the United States is
subsequently destroyed via incineration due in large part to the high waste
treatment efficiencies achieved by the chemical manufacturers. Chemical
manufacturers that submit TRI reports for HCBD byproduct are treating the
chemical via incineration at greater than 99.99% treatment efficiency with some
reporting an efficiency greater than 99.9999%.

Given the known uses and efficiency of the destruction of HCBD created as a
byproduct, EPA is issuing a final rule to prohibit all manufacturing,
processing, and distribution in commerce of HCBD and products and articles
containing HCBD, while recognizing the continuation of the production of HCBD as
a byproduct during the production of chlorinated solvents, and the resulting
processing and distribution of HCBD for burning as a waste fuel. This final rule
allows the current, highly regulated, unintentional production as a byproduct
and incineration and distribution for incineration of such byproduct to continue
and ensures that other uses do not commence.

2. HCBD uses.

Multiple commenters submitted comments to EPA discussing HCBD uses. Commenters
pointed out that EPA's website had previously identified uses of HCBD as a
solvent in rubber manufacturing and in hydraulic, heat transfer, or transformer
fluid (EPA-HQ-OPPT-2019-0080-0575) (EPA-HQ-OPPT-2019-0080-0546). Commenters
further noted that EPA's Preliminary Information on Manufacturing, Processing,
Distribution, Use, and Disposal for HCBD document identified numerous uses for
HCBD beyond its production as a byproduct (Ref. 4) (EPA-HQ-OPPT-2019-0080-0575)
(EPA-HQ-OPPT-2019-0080-0546). According to one commenter, EPA had not addressed
these activities in its proposed rule, much less established that it would be
impracticable to ban these uses to reduce exposure. This commenter stated that
EPA should ban these past uses (EPA-HQ-OPPT-2019-0080-0546). Another commenter
felt that EPA's proposed rule neglected to discuss or mention legacy uses and
legacy disposals of PBT chemicals, and other commenters stated that HCBD has
been listed in Annex A of the Stockholm Convention in order to avoid new
possible future uses of HCBD (EPA-HQ-OPPT-2019-0080-0541)
(EPA-HQ-OPPT-2019-0080-0531) (EPA-HQ-OPPT-2019-0080-0575).

In addition, multiple commenters expressed concerns about EPA's conclusion that
“a prohibition on the manufacture of HCBD would effectively prohibit the
manufacture of the three Start Printed Page 929solvents” (trichloroethylene,
carbon tetrachloride, and perchloroethylene) and therefore that a ban was
impracticable. The commenters made recommendations for alternative regulatory
approaches. One commenter stated that EPA had failed to consider banning HCBD,
except as a byproduct to the manufacture of other chemicals, to reduce exposure
to the extent practicable (EPA-HQ-OPPT-2019-0080-0546). The commenter further
stated that EPA could have considered banning all manufacture except as a
byproduct of manufacture of perchloroethylene, trichloroethylene, and carbon
tetrachloride, to ensure that HCBD is not manufactured for a purpose other than
its incidental production as a byproduct (EPA-HQ-OPPT-2019-0080-0546).

EPA appreciates the comments provided regarding HCBD. EPA's Preliminary
Information on Manufacturing, Processing, Distribution, Use, and Disposal for
HCBD document was a preliminary summary of available information on uses, past
and present, of HCBD (Ref. 4). EPA requested comment on the document but did not
receive confirmation of ongoing uses other than those discussed in the proposed
rule. EPA has not identified any uses of HCBD. The only activity involving HCBD
is burning as a waste fuel as a result of unintentional HCBD production as a
byproduct.

However, recognizing commenters' concern about prohibiting HCBD uses that are
not currently ongoing to avoid, for example, the return of past uses, EPA is
finalizing a change from the proposal and is prohibiting all manufacturing,
processing, and distribution in commerce of HCBD and products and articles
containing HCBD, but allowing the continuation of the unintentional production
of HCBD as a byproduct during the production of chlorinated solvents and the
resulting processing and distribution of HCBD for burning as a waste fuel. This
approach ensures that the types of allowable activities involving HCBD are
severely limited by precluding the manufacture, processing, or distribution of
HCBD for a purpose other than its incidental and unintentional production as a
byproduct and allows burning of that byproduct as a waste fuel. Any other
activity involving HCBD is prohibited by the final rule, and thus the final
requirements are consistent with restrictions on the intentional production and
use of HCBD under Annex A of the Stockholm Convention. Moreover, the highly
regulated burning of the byproduct as a waste fuel is also consistent with
Article 6 of the same Convention. Thus, the final rule requirements reduce the
exposures to humans and the environment that could occur with any activity
involving HCBD not directly related to its manufacture as a byproduct or burning
as a waste fuel.

3. Chlorinated Solvents Resulting in HCBD as a Byproduct.

EPA received comments regarding the chlorinated solvents that unintentionally
produce HCBD as a byproduct. One commenter recommended that EPA consider whether
viable alternative synthetic routes exist that do not result in such production
(EPA-HQ-OPPT-2019-0080-0541). One commenter stated that EPA should solicit
information, regarding whether HCBD-free production methods for chlorinated
solvents exist from industry before concluding that a ban on HCBD would entail a
ban on chlorinated solvents (EPA-HQ-OPPT-2019-0080-0551). Another commenter
stated that EPA must act under section 6(h) to include a total phase-out of the
chemical and any processes that lead to creation of HCBD as a byproduct
(EPA-HQ-OPPT-2019-0080-0575). Others requested EPA require best available
techniques and environmental practices to control emissions and releases from
sources of HCBD, and suggested EPA develop a plan to eliminate HCBD to the
extent practicable through alternative chlorinated solvent manufacturing
(EPA-HQ-OPPT-2019-0080-0567).

EPA appreciates the comments regarding alternatives and actions to be taken on
chlorinated hydrocarbons, particularly perchloroethylene, trichloroethylene, and
carbon tetrachloride, that unintentionally create HCBD as a byproduct. EPA is
not aware of alternative methods for the production of chlorinated solvents that
do not unintentionally produce HCBD as a byproduct and did not receive
additional information in the comments on the proposal. As discussed in the
proposed rule, prohibiting all manufacture of HCBD would effectively preclude
the manufacture of trichloroethylene, carbon tetrachloride and perchloroethylene
and EPA does not believe precluding manufacture of these solvents to reduce the
exposure to the HCBD byproduct is practicable at this time. EPA is not
addressing these three solvents during this TSCA section 6(h) rule making, which
applies solely to PBT chemicals. Additionally, the solvents are the subject of
the risk evaluation process pursuant to TSCA section 6(b). Where unreasonable
risks are identified as part of those risk evaluations, EPA is required to take
action under TSCA section 6(a) to address unreasonable risk. In addition, these
chlorinated solvents are widely used in dry cleaning, metal degreasing, and
other industries. To broadly assess the economic impact of a prohibition of the
manufacture of these three chemicals, EPA estimated the potential market value
loss by multiplying the national production volume of each of these chemicals by
an average price per pound. This resulted in an estimated impact $213 million to
$541 million (average $368 million) worth of production (see the Economic
Analysis for the proposed rule for details on this estimation) (Ref. 10).
Therefore, EPA's final rule allows the continuation of the unintentional
production of HCBD as a byproduct during the production of chlorinated solvents
and processing and distribution of the HCBD byproduct for burning as a waste
fuel, and prohibits all other manufacturing, processing, and distribution in
commerce of HCBD and products and articles containing HCBD.

4. Recordkeeping.

In addition, EPA is requiring that all persons who manufacture, process, or
distribute in commerce HCBD and HCBD-containing products or articles maintain
ordinary business records related to compliance with the prohibitions and
restrictions, such as invoices and bills-of-lading. EPA revised this language
slightly from the proposal to improve clarity. These records will have to be
maintained for a period of three years from the date the record is generated,
beginning on March 8, 2021.

B. TSCA SECTION 6(C)(2) CONSIDERATIONS

1. Health effects, exposure, and environmental effects.

HCBD is toxic to aquatic invertebrates, fish, and birds. Data indicate the
potential for renal, liver, and developmental effects in mammals. HCBD has been
identified as a possible human carcinogen. The studies presented in the Hazard
Summary (Ref. 8) demonstrate these hazardous endpoints. These hazard statements
are not based on a systematic review of the available literature and information
may exist that could refine the hazard characterization. Additional information
about HCBD health effects, use, and exposure is in Unit II.C. and further
detailed in the Hazard Summary (Ref. 8). Information on use and exposures is
also in Unit II.C. and is further detailed in EPA's Exposure and Use Assessment
(Ref. 5, Ref. 8).

2. The benefits of the chemical substance or mixture for various uses.

HCBD is unintentionally manufactured as a waste byproduct by chemical
manufacturers. The majority of Start Printed Page 930what is manufactured is
destroyed via incineration by the manufacturer. A small percentage of the HCBD
is sent off-site for burning as a waste fuel by cement manufacturers.

3. The reasonably ascertainable economic consequences of the rule.

a. Overview of cost methodology.

EPA has evaluated the potential costs of the final action for HCBD. Costs of the
final rule were estimated based on the assumption that under regulatory
limitations on HCBD, processors that use HCBD in their products would switch to
available alternative chemicals to manufacture the product, or to products that
do not contain HCBD. Costs for rule familiarization and recordkeeping were
estimated based on burdens estimated for other similar rulemakings. Costs were
annualized over a 25-year period. Other potential costs include, but are not
limited to, those associated with testing, reformulation, imported articles, and
some portion of potential revenue loss. However, these costs are discussed only
qualitatively, due to lack of data availability to estimate quantified costs.
More details of this analysis are presented in the Economic Analysis (Ref. 3).

b. Estimated costs of this final rule.

Total quantified annualized industry costs for the final rule is $354. Total
annualized Agency costs associated with implementation of the final rule were
based on EPA's best judgment and experience with other similar rules. For the
final regulatory action, EPA estimates it will require 0.5 FTE at $77,576 per
year (Ref. 3).

Total quantified annualized social costs for the final rule are estimated to be
$77,930 (at both 3% and 7% discount rates annualized over 25 years). As
described earlier in Unit III.B.3, potential costs such as testing,
reformulation, and imported articles, could not be quantified due to lack of
data availability to estimate quantified costs. These costs are discussed
qualitatively in the Economic Analysis (Ref. 3).

c. Benefits.

As discussed in Unit II., although EPA reviewed hazard and exposure information
for the PBT chemicals, this information did not provide a basis for EPA to
develop scientifically robust and representative risk estimates to evaluate
whether or not any of the chemicals present a risk of injury to health or the
environment. Benefits were not quantified due to the lack of risk estimates. A
qualitative discussion of the potential benefits associated with the final
action for HCBD is provided. HCBD is persistent, bioaccumulative, and a possible
human carcinogen. It is not intentionally manufactured in the United States.
Since EPA is effectively excluding from prohibition all current activities
involving HCBD as a byproduct, no benefits to human health or the environment
are expected; the benefit is the prevention of individuals from being
occupationally exposed to HCBD via the inhalation and dermal routes in the
future. The toxicity of potential substitutes for HCBD has not been assessed at
this time.

d. Cost effectiveness, and effect on national economy, small business, and
technological innovation.

With respect to the cost effectiveness of the final regulatory action and the
primary alternative regulatory action, EPA is unable to perform a traditional
cost-effectiveness analysis of the actions and alternatives for the PBT
chemicals. As discussed in the proposed rule, the cost effectiveness of a policy
option would properly be calculated by dividing the annualized costs of the
option by a final outcome, such as cancer cases avoided, or to intermediate
outputs such as tons of emissions of a pollutant curtailed. Without the
supporting analyses for a risk determination, EPA is unable to calculate either
a health-based or environment-based denominator. Thus, EPA is unable to perform
a quantitative cost-effectiveness analysis of the final and alternative
regulatory actions. However, by evaluating the practicability of the final and
alternative regulatory actions, EPA believes that it has considered elements
related to the cost effectiveness of the actions, including the cost and the
effect on exposure to the PBT chemicals of the final and alternative regulatory
actions.

EPA considered the anticipated effect of this rule on the national economy and
concluded that this rule is highly unlikely to have any measurable effect on the
national economy (Ref. 3). EPA analyzed the expected impacts on small business
and found that no small entities are expected to experience impacts of more than
1% of revenues (Ref. 3). Finally, EPA has determined that this rule is unlikely
to have significant impacts on technological innovation.

4. Consideration of alternatives.

EPA has not identified any uses of HCBD. Therefore, chemical alternatives were
not considered.

C. TSCA SECTION 26(H) CONSIDERATIONS

In accordance with TSCA section 26(h) and taking into account the requirements
of TSCA section 6(h), EPA has used scientific information, technical procedures,
measures, and methodologies that are fit for purpose and consistent with the
best available science. For example, EPA based its determination that human and
environmental exposures to the HCBD byproduct are likely in the Exposure and Use
Assessment (Ref. 5) discussed in Unit II.A.2, which underwent a peer review and
public comment process, as well as using best available science and methods
sufficient to make that determination. The extent to which the various
information, procedures, measures, and methodologies, as applicable, used in
EPA's decision making have been subject to independent verification or peer
review is adequate to justify their use, collectively, in the record for this
final rule. Additional information on the peer review and public comment
process, such as the peer review plan, the peer review report, and the Agency's
response to comments, are in the public docket for this action
(EPA-HQ-OPPT-2019-0080). In addition, in accordance with TSCA section 26(i), and
taking into account the requirements of TSCA section 6(h), EPA has made
scientific decisions based on the weight of the scientific evidence.

IV. REFERENCES

The following is a list of the documents that are specifically referenced in
this document. The docket includes these documents and other information
considered by EPA, including documents that are referenced within the documents
that are included in the docket, even if the referenced document is not
physically located in the docket. All records in docket EPA-HQ-OPPT-2019-0080
are part of the record for this rulemaking. For assistance in locating these
other documents, please consult the technical person listed under FOR FURTHER
INFORMATION CONTACT.

1. EPA. TSCA Work Plan for Chemical Assessments: 2014 Update. October 2014.
https://www.epa.gov/ assessingand-managing-chemicals-under-tsca/
tsca-work-plan-chemical-ssessments-2014-update. Accessed March 1, 2019.

2. EPA. TSCA Work Plan Chemicals: Methods Document. February 2012.
https://www.epa.gov/ sites/ production/ files/ 2014-03/ documents/ work_ plan_
methods_ document_ web_ final.pdf. Accessed March 1, 2019.

3. EPA. Economic Analysis for Regulation of Hexachlorobutadiene (HCBD) Under
TSCA Section 6(h). December 2020.

4. EPA. Regulation of Persistent, Bioaccumulative, and Toxic Chemicals Under
TSCA Section 6(h). Response to Public Comments. December 2020. (Docket
EPA-HQ-OPPT-2019-0080).Start Printed Page 931

5. EPA. Exposure and Use Assessment of Five Persistent, Bioaccumulative, and
Toxic Chemicals. December 2020.

6. United Nations Environment Program Stockholm Convention on Persistent Organic
Pollutants (2012). Risk profile on hexachlorobutadiene. Report of the Persistent
Organic Pollutants Review Committee on the work of its eighth meeting.

7. EPA. Preliminary Information on Manufacturing, Processing, Distribution, Use,
and Disposal: Hexachlorobutadiene. August 2017. (EPA-HQ-OPPT-2016-0738-0004).

8. EPA. Environmental and Human Health Hazards of Five Persistent,
Bioaccumulative and Toxic Chemicals. December 2020.

9. EPA. National Emission Standards for Hazardous Air Pollutants: Miscellaneous
Organic Chemical Manufacturing; Final Rule. Federal Register (63 FR 63852, Nov.
10, 2003) (FRL-7551-3)

10. EPA. Economic Analysis for Proposed Regulation of Persistent,
Bioaccumulative, and Toxic Chemicals under TSCA section 6(h). June 2019.

11. Keweenaw Bay Indian Community. Re: Notification of Consultation and
Coordination on a Rulemaking Under the Toxic Substances Control Act: Regulation
of Persistent, Bioaccumulative, and Toxic Chemicals Under TSCA Section 6(h).
September 25, 2018.

12. Harper, Barbara and Ranco, Darren, in collaboration with the Maine Tribes.
Wabanaki Traditional Cultural Lifeways Exposure Scenario. July 9, 2009.

V. STATUTORY AND EXECUTIVE ORDER REVIEWS

Additional information about these statutes and Executive Orders can be found at
https://www.epa.gov/ laws-regulations-and-executive-orders.

A. EXECUTIVE ORDER 12866: REGULATORY PLANNING AND REVIEW AND EXECUTIVE ORDER
13563: IMPROVING REGULATIONS AND REGULATORY REVIEW

This action is a significant regulatory action that was submitted to the Office
of Management and Budget (OMB) for review under Executive Orders 12866 (58 FR
51735, October 4, 1993) and 13563 (76 FR 3821, January 21, 2011). Any changes
made in response to OMB recommendations have been documented in the docket for
this action as required by section 6(a)(3)(E) of Executive Order 12866.

EPA prepared an economic analysis of the potential costs and benefits associated
with this action. A copy of this economic analysis, Economic Analysis for Final
Regulation of Hexachlorobutadiene (HCBD) Under TSCA Section 6(h) (Ref. 3) is in
the docket and is briefly summarized in Unit III.B.3.

B. EXECUTIVE ORDER 13771: REDUCING REGULATION AND CONTROLLING REGULATORY COSTS

This action is considered a regulatory action under Executive Order 13771 (82 FR
9339, February 3, 2017). Details on the estimated costs of this final rule can
be found in the Economic Analysis (Ref. 3), which is briefly summarized in Unit
III.B.3.

C. PAPERWORK REDUCTION ACT (PRA)

The information collection activities in this rule have been submitted for
approval to the OMB under the PRA, 44 U.S.C. 3501 et seq. The Information
Collection Request (ICR) document that the EPA prepared has been assigned EPA
ICR number 2599.02 and OMB Control No. 2070-0213. A copy of the ICR is available
in the docket for this rule, and it is briefly summarized here. The information
collection requirements are not enforceable until OMB approves them.

Respondents/affected entities: Entities potentially affected by paperwork
requirements of this final rule include manufacturers (including importers),
processors, and distributors of HCBD.

Respondent's obligation to respond: Mandatory (40 CFR 751.413).

Estimated number of respondents: 9.

Frequency of response: On occasion.

Total estimated burden: 4.5 hours (per year). Burden is defined at 5 CFR
1320.3(b).

Total estimated cost: $354 (per year), includes $0 annualized capital or
operation & maintenance costs.

The ICR submitted to OMB for approval under OMB Control No. 2070-0213 addresses
the paperwork requirements of this final rule as well as the paperwork
requirements of the other final rules addressing PBT chemicals under TSCA
section 6(h) promulgated by EPA elsewhere in this issue of the Federal Register.
For the combined paperwork requirements of all five final rules, EPA estimates a
total of 102 respondents, 88 burden hours (per year), and a cost of
approximately $6,920 (per year) that includes no annualized capital or operation
and maintenance costs.

An agency may not conduct or sponsor, and a person is not required to respond
to, a collection of information unless it displays a currently valid OMB control
number. The OMB control numbers for EPA's regulations in 40 CFR are listed in 40
CFR part 9. When OMB approves this ICR, the Agency will announce that approval
in the Federal Register and publish a technical amendment to 40 CFR part 9 to
display the OMB control number for the approved information collection
activities contained in this final rule and the other final rules addressing PBT
chemicals under TSCA section 6(h).

D. REGULATORY FLEXIBILITY ACT (RFA)

I certify that this action will not have a significant economic impact on a
substantial number of small entities under the RFA, 5 U.S.C. 601 et seq. One
small business, an importer, is expected to be affected by the rule
familiarization and recordkeeping requirements of the final rule. The one small
entity assessed is not expected to incur impacts of 1% (or greater) of their
revenue. Because this entity's impacts are less than 1%, EPA presumes no
significant economic impact on a substantial number of small entities. Details
of this analysis are presented in the Economic Analysis (Ref. 3).

E. UNFUNDED MANDATES REFORM ACT (UMRA)

This action does not contain an unfunded mandate of $100 million or more as
described in UMRA, 2 U.S.C. 1531-1538, and will not significantly or uniquely
affect small governments. The final rule is not expected to result in
expenditures by State, local, and Tribal governments, in the aggregate, or by
the private sector, of $100 million or more (when adjusted annually for
inflation) in any one year. Accordingly, this final rule is not subject to the
requirements of sections 202, 203, or 205 of UMRA. The total quantified
annualized social costs for this final rule are approximately $77,900 (at both
3% and 7% discount rate), which does not exceed the inflation-adjusted unfunded
mandate threshold of $160 million.

F. EXECUTIVE ORDER 13132: FEDERALISM

This action does not have federalism implications because it is not expected to
have substantial direct effects on the states, on the relationship between the
national government and the states, or on the distribution of power and
responsibilities among the various levels of government as specified in
Executive Order 13132 (64 FR 43255, August 10, 1999). Thus, Executive Order
13132 does not apply to this action.

G. EXECUTIVE ORDER 13175: CONSULTATION AND COORDINATION WITH INDIAN TRIBAL
GOVERNMENTS

This action does not have tribal implications because it is not expected to have
substantial direct effects on tribal governments, on the relationship between
the Federal Government and the Indian tribes, or on the distribution of power
and responsibilities between the Federal Government and Indian Start Printed
Page 932tribes as specified in Executive Order 13175 (65 FR 67249, November 9,
2000). Thus, Executive Order 13175 does not apply to this final rule.

Consistent with the EPA Policy on Consultation and Coordination with Indian
Tribes, EPA consulted with tribal officials during the development of this
action. EPA consulted with representatives of Tribes via teleconference on
August 31, 2018, and September 6, 2018, concerning the prospective regulation of
the five PBT chemicals under TSCA section 6(h).

Tribal members were encouraged to provide additional comments after the
teleconferences. EPA received two comments from the Keweenaw Bay Indian
Community and Maine Tribes (Refs. 11 and 12).

H. EXECUTIVE ORDER 13045: PROTECTION OF CHILDREN FROM ENVIRONMENTAL HEALTH AND
SAFETY RISKS

This action is not subject to Executive Order 13045 (62 FR 19885, April 23,
1997) because it is not an economically significant regulatory action as defined
by Executive Order 12866. While the action is not subject to Executive Order
13045, the Agency considered the risks to infants and children under EPA's
Policy on Evaluating Health Risks to Children. EPA did not perform a risk
assessment or risk evaluation of HCBD, the available data indicate exposure to
HCBD may disproportionately affect children, and effects information indicating
developmental effects. This regulation will reduce the exposure to HCBD that
could occur from the prohibited activities for the general population and for
potentially exposed or susceptible subpopulations such as children. More
information can be found in the Exposure and Use Assessment (Ref. 5).

I. EXECUTIVE ORDER 13211: ACTIONS CONCERNING REGULATIONS THAT SIGNIFICANTLY
AFFECT ENERGY SUPPLY, DISTRIBUTION, OR USE

This action is not a “significant energy action” as defined in Executive Order
13211 (66 FR 28355, May 22, 2001) because it is not likely to have a significant
adverse effect on the supply, distribution, or use of energy and has not
otherwise been designated by the Administrator of the Office of Information and
Regulatory Affairs as a significant energy action.

J. NATIONAL TECHNOLOGY TRANSFER AND ADVANCEMENT ACT (NTTAA).

This rulemaking does not involve any technical standards. Therefore, NTTAA
section 12(d), 15 U.S.C. 272 note, does not apply to this action.

K. EXECUTIVE ORDER 12898: FEDERAL ACTIONS TO ADDRESS ENVIRONMENTAL JUSTICE IN
MINORITY POPULATIONS AND LOW-INCOME POPULATIONS

EPA believes that this action does not have disproportionately high and adverse
health or environmental effects on minority populations, low-income populations
and/or indigenous peoples, as specified in Executive Order 12898 (59 FR 7629,
February 16, 1994). The documentation for this decision is contained in the
Economic Analysis (Ref. 3), which is in the public docket for this action. EPA
believes that the restrictions on HCBD in this final rule will reduce the
potential for exposure in the United States, thus benefitting all communities,
including environmental justice communities.

L. CONGRESSIONAL REVIEW ACT (CRA)

This action is subject to the CRA, 5 U.S.C. 801 et seq., and EPA will submit a
rule report to each House of the Congress and to the Comptroller General of the
United States. This action is not a “major rule” as defined by 5 U.S.C. 804(2).

Start List of Subjects

LIST OF SUBJECTS IN 40 CFR PART 751

* Environmental protection
* Chemicals
* Export Notification
* Hazardous substances
* Import certification
* Reporting and recordkeeping

End List of Subjects Start Signature

Andrew Wheeler,

Administrator.

End Signature

Therefore, for the reasons stated in the preamble, 40 CFR part 751 is amended as
follows:

Start Part

PART 751—REGULATION OF CERTAIN CHEMICAL SUBSTANCES AND MIXTURES UNDER SECTION 6
OF THE TOXIC SUBSTANCES CONTROL ACT

End Part Start Amendment Part

1. The authority citation for part 751 continues to read as follows:

End Amendment Part Start Authority

Authority: 15 U.S.C. 2605, 15 U.S.C. 2625(l)(4).

End Authority Start Amendment Part

2. Amend § 751.403 by adding in alphabetical order the term “HCBD” to read as
follows:

End Amendment Part

SUBPART E—PERSISTENT, BIOACCUMULATIVE, AND TOXIC CHEMICALS

§ 751.403
Definitions.
* * * * *

HCBD means the chemical substance hexachlorobutadiene (CASRN 87-68-3).

* * * * *
Start Amendment Part

3. Add § 751.413 to read as follows:

End Amendment Part
§ 751.413
HCBD.

(a) Prohibition. After March 8, 2021, all persons are prohibited from all
manufacturing, processing and distribution in commerce of HCBD and
HCBD-containing products or articles, except for the following:

(1) Unintentional production of HCBD as a byproduct in the production of
chlorinated solvents; and

(2) Processing and distribution in commerce of HCBD for burning as a waste fuel.

(b) Recordkeeping. After March 8, 2021, manufacturers, processors and
distributors of HCBD or HCBD-containing products or articles must maintain
ordinary business records related to compliance with the prohibitions,
restrictions and other provisions of this section, such as invoices and
bills-of-lading. These records must be maintained for a period of three years
from the date the record is generated.

End Supplemental Information

[FR Doc. 2020-28693 Filed 1-5-21; 8:45 am]

BILLING CODE 6560-50-P

PUBLISHED DOCUMENT

HOME

* Home

SECTIONS

* Money
* Environment
* World
* Science & Technology
* Business & Industry
* Health & Public Welfare

BROWSE

* Agencies
* Topics (CFR Indexing Terms)
* Dates
* Public Inspection
* Executive Orders

* Document Search
* Advanced Document Search
* Public Inspection Search

READER AIDS

* Office of the Federal Register Blog
* Using FederalRegister.Gov
* Understanding the Federal Register
* Recent Site Updates
* Videos & Tutorials
* Developer Resources
* Government Policy and OFR Procedures
* Congressional Review

MY FR

* My Clipboard
* My Subscriptions
* My Comments
* Sign In

SOCIAL MEDIA

* Facebook
* Twitter

INFORMATION

* About This Site
* Legal Status
* Contact Us
* Privacy
* Accessibility
* FOIA
* No Fear Act
* Continuity Information

Site Feedback

www.federalregister.gov Open in urlscan Pro 99.83.174.136 Public Scan

Form analysis 6 forms found in the DOM

GET /topics

GET /topics

GET /document_issues/search

GET /public_inspection_issues/search

GET /documents/search

POST /my/clippings

Text Content

www.federalregister.gov Open in urlscan Pro
99.83.174.136 Public Scan

Form analysis
6 forms found in the DOM